Development of Polymer-Lipid Hybrid Nanoparticles for Large-Sized Plasmid DNA Transfection
Description
RNA and DNA delivery technologies using lipid nanoparticles (LNPs) have advanced significantly, as demonstrated by their successful application in mRNA vaccines. To date, commercially available RNA therapeutics include Onpattro, a 21 bp siRNA, and
